MAPT and Alzheimer disease: One of the first tau peptide vaccines was created by Asuni et al. and was tested in an AD tau mouse model.[25] The vaccine consists of tau393–408 with phosphorylated serine at positions 396 and 404 in Adju‐Phos adjuvant.